Welcome to LookChem.com Sign In|Join Free
  • or
4-(octylamino)-4-oxobut-2-enoic acid is a chemical compound with the molecular formula C12H21NO3. It is an organic compound characterized by a but-2-enoic acid backbone, which features a double bond between the second and third carbon atoms. The molecule also contains an octylamine group attached to the fourth carbon, which is a straight-chain alkyl group with eight carbon atoms. 4-(octylamino)-4-oxobut-2-enoic acid is known for its potential applications in the synthesis of various pharmaceuticals and agrochemicals, particularly as an intermediate in the production of certain drugs and pesticides. Its structure provides a balance of lipophilic and hydrophilic properties, which can influence its solubility and reactivity in different chemical processes.

3151-55-1

Post Buying Request

3151-55-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3151-55-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 3151-55-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,1,5 and 1 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 3151-55:
(6*3)+(5*1)+(4*5)+(3*1)+(2*5)+(1*5)=61
61 % 10 = 1
So 3151-55-1 is a valid CAS Registry Number.

3151-55-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(octylamino)-4-oxobut-2-enoic acid

1.2 Other means of identification

Product number -
Other names N-octyl-maleimic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3151-55-1 SDS

3151-55-1Relevant academic research and scientific papers

Chlorin photosensitizers sterically designed to prevent self-aggregation

Uchoa, Adjaci F.,De Oliveira, Kleber T.,Baptista, Mauricio S.,Bortoluzzi, Adailton J.,Iamamoto, Yassuko,Serra, Osvaldo A.

, p. 8824 - 8832 (2011)

The synthesis and photophysical evaluation of new chlorin derivatives are described. The Diels-Alder reaction between protoporphyrin IX dimethyl ester and substituted maleimides furnishes endo-adducts that completely prevent the self-aggregation of the chlorins. Fluorescence, resonant light scattering (RLS) and 1H NMR experiments, as well as X-ray crystallographic have demonstrated that the configurational arrangement of the synthesized chlorins prevent π-stacking interactions between macrocycles, thus indicating that it is a nonaggregating photosensitizer with high singlet oxygen (ΦΔ) and fluorescence (Φf) quantum yields. Our results show that this type of synthetic strategy may provide the lead to a new generation of PDT photosensitizers.

A deep, water-soluble cavitand acts as a phase-transfer catalyst for hydrophobic species

Hooley, Richard J.,Biros, Shannon M.,Rebek Jr., Julius

, p. 3517 - 3519 (2007/10/03)

Overcoming inhibition: A deep, water-soluble cavitand has been shown to extract various N-substituted maleimides into aqueous solution through the hydrophobic effect. These complexes react with a water-soluble thiol to confer water solubility to the produ

MYCOBACTERIAL INHIBITORS

-

Page/Page column 8, (2010/11/08)

The invention provides the use of certain succinimide compounds in the treatment of mycobacterial diseases.

Design, synthesis, and biochemical evaluation of N-substituted maleimides as inhibitors of prostaglandin endoperoxide synthases

Kalgutkar, Amit S.,Crews, Brenda C.,Marnett, Lawrence J.

, p. 1692 - 1703 (2007/10/03)

N-(Carboxyalkyl)maleimides are rapid as well as time-dependent inhibitors of prostaglandin endoperoxide synthase (PGHS). The corresponding N- alkylmaleimides were only time-dependent inactivators of PGHS, suggesting that the carboxylate is critical for rapid inhibition. Several N-substituted maleimide analogs containing structural features similar to those of the nonsteroidal anti-inflammatory drug aspirin were synthesized and evaluated as inhibitors of PGHS. Most of the aspirin-like maleimides inactivated the cyclooxygenase activity of purified ovine PGHS-1 in a time- and concentration-dependent manner similar to that of aspirin. The peroxidase activity of PGHS was also inactivated by the maleimide analogs. The cyclooxygenase activity of the inducible isozyme, i.e., PGHS-2, was also inhibited by these compounds. The corresponding succinimide analog of N-5- maleimido-2-acetoxy-1-benzoic acid did not inhibit either enzyme activity, suggesting that inactivation was due to covalent modification of the protein. The mechanism of inhibition of PGHS-1 by N-(carboxyheptyl)maleimide was investigated. Incubation of apoPGHS-1 with 2 equiv of N-(carboxyheptyl)[3,4- 14C]maleimide led to the incorporation of radioactivity in the protein, but no adduct was detected by reversed-phase HPLC, suggesting that it was unstable to the chromatographic conditions. Furthermore, hematin- reconstituted PGHS-1, which was rapidly inhibited by N- (carboxyheptyl)maleimide, displayed spontaneous regeneration of about 50% of the cyclooxygenase and peroxidase activities, suggesting that the adduct responsible for the inhibition breaks down to regenerate active enzyme. ApoPGHS-1, inhibited by N-(carboxyheptyl)maleimide, did not display regeneration of enzyme activity, but addition of hematin to the inhibited apoenzyme led to spontaneous recovery of about 50% of cyclooxygenase activity. These results suggest that addition of heme leads to a conformational change in the protein which increases the susceptibility of the adduct toward hydrolytic cleavage. ApoPGHS-1, pretreated with N(carboxyheptyl)maleimide, was resistant to trypsin cleavage, suggesting that the carboxylate functionality of the maleimide binds in the cyclooxygenase channel. A model for the interaction of N-(carboxyheptyl)maleimide in the cyclooxygenase active site is proposed.

COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF CYCLOOXYGENASE ACTIVITY

-

, (2008/06/13)

The present invention includes N-substituted maleimides (1(H)-Pyrrole-2,5-dione (Maleimide) analogs and succinimides which act as potent nonsteroidal anti-inflammatory drugs and are capable of dual inactivation or selective inactivation of the cyclooxygenase and the peroxidase activities of prostaglandin endoperoxide synthase (PGHS).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 3151-55-1